MODER DIABETOLOGY Basic science andclincial practice. Questo articolo non è disponibile.MODER DIABETOLOGY Basic science andclincial practice

Despite extraordinary therapeutic advances since the discovery of insulin 100 years ago, diabetes prevalence continues to rise and significant challenges remain. Modern Diabetology: Basic Science and Clinical Practice provides a concise, one-stop reference that consolidates rapidly evolving research and clinical practice guidelines for today’s endocrinologists, general surgeons, internists, and primary care physicians. Provides up-to-date coverage of basic science, translational advances, and clinical management in one accessible text, serving as a critical reference for practitioners navigating fast-moving developments in the field Features 24 chapters authored by internationally recognized experts in diabetes research and clinical practice Offers in-depth updates on rapidly advancing areas including MODY, hormonal biology, Types 1 and 2 diabetes genetics, immune mechanisms, and oxidative stress and complications Covers cutting-edge therapeutic strategies such as SGLT2 inhibitors, GLP1 - receptor agonists, glucose sensors and pumps, stem cell therapy, and pancreas and islet transplantation An eBook version is included with purchase. The eBook allows you to access all of the text, figures, and references, with the ability to search, make notes and highlights, and have content read aloud. Additional digital ancillary content may publish after the publication date

R. Paul Robertson, M.D. is an Emeritus Professor of Medicine at the University of Washington and at the University of Minnesota.
Dr. Robertson has published 395 peer-reviewed manuscripts with primary emphasis on pancreatic islet function in humans, animals, and clonal cell lines. His early studies were the first to demonstrate defects involving the adverse effects of glucose toxicity on the critical insulin promoters Pdx-1 and MafA associated with glucose toxicity. More recent research demonstrated adverse metabolic consequences of using the liver as a transplant site for pancreatic islet transplantation in patients with type 1 diabetes mellitus and in autoislet recipients following pancreatectomy for chronic, painful pancreatitis.